Newsroom | 1926 results

DOVER, Del.--(BUSINESS WIRE)--Identy.io, a leader in biometric identification, and My Family ID, the only Child ID & Senior ID app with in-app fingerprinting and face scanning, are partnering to provide instant digital fingerprinting for children, removing the need for physical records. According to the FBI and the Center for Missing and Exploited Children, fingerprinting a child is the most important thing a parent or guardian can do to ensure law enforcement can quickly identify a child i...

NEWARK, N.J.--(BUSINESS WIRE)--Lura Health and SCO Group form a strategic partnership to introduce non-invasive, continuous health monitoring through saliva....

GENEVA, Switzerland--(BUSINESS WIRE)--Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, today announced a new clinical research partnership with the National Spine Health Foundation (NSHF) - a nonprofit organization dedicated to patient education, research, and advocacy. The study, coordinated by NSHF and conducted at Mayo Clinic under the direction of Benjamin Elder, M.D., Ph.D., neurosurgeon and principal investigator, will evaluate the role of TBS Re...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced the completion of patient enrollment in the second cohort of its Phase 1/2 Audiogene clinical trial evaluating SENS-501, the Company’s gene therapy candidate being developed to treat a specific form of congenital deafness linked to mutatio...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN), société pionnière de biotechnologie au stade clinique, spécialisée dans le développement de nouvelles thérapies pour restaurer, traiter et prévenir les troubles de la perte auditive, annonce aujourd'hui la fin du recrutement des patients de la deuxième cohorte de son essai clinique de Phase 1/2 Audiogene évaluant le SENS-501, la thérapie génique développée par la Société pour traiter une forme spécifique de...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter glucose biosensor cleared1 by the FDA in the United States, following the feature’s launch on Dexcom G7 earlier this year. Dexcom’s Smart Food Logging feature encourages and enables users to log their meals more consistently. Stelo and Dexcom G7 users can now simply take a photo of their food in the ap...

DUBLIN--(BUSINESS WIRE)--The "The Global Wearable Technology Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The Global Wearable Technology Market 2026-2036 is a comprehensive 1,200-page market report providing an exhaustive analysis of the wearable technology ecosystem from 2026 to 2036, offering unprecedented insights into market dynamics, emerging technologies, and future growth opportunities across consumer electronics, medical applications, and industrial sect...

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce second quarter 2025 financial results after market close on Thursday, August 7, 2025. Owlet’s Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic)...

PITTSBURGH--(BUSINESS WIRE)--Plexision, a biotechnology company, today announced a $365,000 investment from the Richard King Mellon Foundation. The funds will be used to accelerate the integration of artificial intelligence (AI) and machine learning (ML) capabilities across Plexision’s suite of cell-based blood tests, significantly improving predictive accuracy for complex transplant outcomes. Despite advances in transplant medicine, managing immunosuppressive drugs remains a delicate balance....

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (“Know Labs” or the “Company”), a technology innovator specializing in non-invasive health monitoring solutions, today issued a reminder to its stockholders to vote ahead of the Special Meeting of Stockholders (the “Special Meeting”) to be held virtually on Thursday, July 24, 2025 at 1:30 p.m. pacific time. The methods for voting and submitting proxies are described in the previously distributed proxy materials for the Special Meeti...